ARTICLE | Company News
Apricus Biosciences management update
November 12, 2012 8:00 AM UTC
Apricus Biosciences Inc. (NASDAQ:APRI), San Diego, Calif. Business: Drug delivery, Genitourinary, Cancer Transitioned: Steve Martin, SVP and CFO, to interim CEO; he replaces Bassam Damaj who resigned ...